Cenedella.de

Patient Advocate since 1977.


Leave a comment

BERLIN PEACE ACCORDS “ein Ende des Weltkriegs gegen Cannabis”

Cenedella.de

Von: Philip J. Cenedella IV

http://www.Cenedella.de

31. März 2017 Berlin, Deutschland

BERLIN PEACE ACCORDS “ein Ende des Weltkriegs gegen Cannabis” (Das Berliner Friedensabkommen wird auf der ICBC-Berlin-Konferenz am 12. April 2017 unterzeichnet)

Am 10.-12. April 2017 werden Hunderte von internationalen Führungskräften in der Cannabis-Industrie in Berlin zusammenarbeiten. Viele nennen sie die bedeutendste und historischste Cannabis- Konferenz in Europa: die Internationale Cannabis-Business-Konferenz kurz ICBC, http://www.internationalcbc.com

Die BERLIN PEACE ACCORDS, die dem Weltkrieg gegen Cannabis ein Ende setzen möchten, werden offiziell den Medien und allen Teilnehmer*innen auf einer Pressekonferenz, die am 12. April stattfinden wird, vorgestellt. Im Vorfeld vom Treffen zwischen Präsident Trump und Bundeskanzlerin Merkel in Hamburg, Deutschland im Juli 2017, haben Cannabis-Befürworter*innen ein Dokument erstellt, dass die nationalen Führer*innen und alle Regierungen weltweit adressiert, um ihre Bemühungen sofort zu koordinieren und die Kampagne der Intoleranz und der Inhaftierung zu beenden. Quantum 9, Cenedella.de und viele andere unterzeichnen die BERLIN PEACE…

View original post 543 more words


1 Comment

BERLIN PEACE ACCORDS – “putting a just end to the world war on Cannabis!”

Philip J. Cenedella IV
http://www.Cenedella.de
27 March 2017
Berlin, Germany

BERLIN  PEACE  ACCORDS  “putting a just end to the world war on Cannabis!”

(The Berlin Peace Accords to be signed at the ICBC-Berlin Conference on April 12, 2017)

On April 10-12, 2017 hundreds of international leaders in the Cannabis Industry will be assembling in Berlin for what many are calling the most significant and historic cannabis conference in Europe ever –  The International Cannabis Business Conference www.internationalcbc.com

The BERLIN  PEACE  ACCORDS  “putting a just end to the world war on Cannabis!” will be officially introduced to the media and all attendees at a press conference to be held on April 12th.  In advance of President Trump and Chancellor Merkel’s meeting in Hamburg, Germany this July, cannabis advocates have constructed a document calling on those national leaders, and all governments worldwide, to immediately coordinate their efforts and put an end to the campaign of intolerance and incarceration.  Quantum 9,  Cenedella.de and many others will be signing the BERLIN PEACE ACCORDS and presenting it directly to Senator Rohrabacher of the U.S. Congress for action.  We invite Industry professionals to contact us to be involved even if you are unable to attend in person.

So what is happening in Germany today and how will it impact you and your company?

Good questions, with multiple answers, but it really comes down to the fact that Germany has now implemented a comprehensive medical marijuana distribution program with the March 9th registration of the “Cannabis as Medicine” Act <Bundesgesetzblatt Teil I 2017 Nr. 11>   This is a historic moment in our movement for the regulation, legalization, social acceptance of our plant and we commend the advocates on the frontlines of this decades-long fight, most notably Mr. George Wurth of the Hemp Association and a Speaker at ICBC Berlin.  The ICBC Berlin event could not be happening in a better location nor be any more timely.  We salute Alex Rogers and his incredibly professional team for having the foresight to make this event happen and we welcome everyone in the industry to join us in Berlin from April 10-12th!

With over twice the population of California in half the space, Germany is key to the formation of a legal, reliable and professional Cannabis industry within the entire European Union.  The Bundesinstitut fur Arzneimittel und Medizinprodukte (BfArM) in Bonn is a government organization and your central point of contact for all things Cannabis.  Currently the German government imports all medicine for patients exclusively from Canada and the Netherlands, with the stated goal of developing a robust, and pharmaceutical-grade grow industry within its own borders by 2019.

Pharmacies in Germany are managed by the State Office of Health and Social Affairs and are going to be the only distribution point for pre-approved medical marijuana products.  The Pharmacy situation here is really quite different than in America with medically-trained staff at thousands of locations only now learning of how to implement this new law and serve their patients effectively.   There are numerous opportunities for companies, consultants and organizations to help fill the void with a recent estimate calculating the need for over 500,000 lbs. of pharmaceutical-grade medical marijuana needed per year.

The medical and therapeutic uses of cannabis are extremely important but the calls for recreational implementation is also at the top of the agenda for many.  During the past few years a few German cities have started the process of establishing a German recreational marketplace and although Berlin has been stymied in its efforts to date, the upcoming national elections may have a positive impact on those efforts.  The City of Dusseldorf has a pilot project to sell recreational cannabis to adults slated to start this summer and other German cities are working on similar measures at the behest of their citizens.   Germany is indeed central to the success of a legal, professional and workable European cannabis marketplace.  Countries that will also have a significant impact on the future of the EU industry include:  Canada, Netherlands, Switzerland, Albania, Spain, United Kingdom, Israel and the USA.

We invite you to ICBC Berlin on April 10-12th at the Maritim ProArte Hotel Berlin.  Stop by our tabletop and note that for all attendees we will providing free phone calls to the USA, free wifi, and free electric plug-in for all those that forget their European adapters J   Any comments or questions on this post are welcomed by contacting me directly at  phil@cenedella.de , +1.888.206.3264 or via skype at  philip.j.cenedella.

 

Thank you, Dank je, Gracias, and Danke schoene,

  • Phil


1 Comment

BERLIN PEACE ACCORDS “ein Ende des Weltkriegs gegen Cannabis”

Von: Philip J. Cenedella IV

http://www.Cenedella.de

31. März 2017 Berlin, Deutschland

BERLIN PEACE ACCORDS “ein Ende des Weltkriegs gegen Cannabis” (Das Berliner Friedensabkommen wird auf der ICBC-Berlin-Konferenz am 12. April 2017 unterzeichnet)

Am 10.-12. April 2017 werden Hunderte von internationalen Führungskräften in der Cannabis-Industrie in Berlin zusammenarbeiten. Viele nennen sie die bedeutendste und historischste Cannabis- Konferenz in Europa: die Internationale Cannabis-Business-Konferenz kurz ICBC, http://www.internationalcbc.com

Die BERLIN PEACE ACCORDS, die dem Weltkrieg gegen Cannabis ein Ende setzen möchten, werden offiziell den Medien und allen Teilnehmer*innen auf einer Pressekonferenz, die am 12. April stattfinden wird, vorgestellt. Im Vorfeld vom Treffen zwischen Präsident Trump und Bundeskanzlerin Merkel in Hamburg, Deutschland im Juli 2017, haben Cannabis-Befürworter*innen ein Dokument erstellt, dass die nationalen Führer*innen und alle Regierungen weltweit adressiert, um ihre Bemühungen sofort zu koordinieren und die Kampagne der Intoleranz und der Inhaftierung zu beenden. Quantum 9, Cenedella.de und viele andere unterzeichnen die BERLIN PEACE ACCORDS und präsentieren sie direkt an Senator Rohrabacher vom U.S. Kongress zum Handeln.

Wir laden Fachleute der Industrie ein, mit uns in Kontakt zu treten, auch wenn Sie nicht persönlich teilnehmen können.

Was geschieht heute in Deutschland und wie wird es Sie und Ihr Unternehmen beeinflussen?

Gute Fragen, mit vielfältigen Antworten, aber es kommt wirklich darauf an, dass Deutschland nun mit dem 9. März ein umfangreiches medizinisches Marihuana-Verteilungsprogramm umgesetzt hat: das neue Gesetz “Cannabis als Medizin” Dies ist ein historischer Moment in unserer Bewegung für die Regulierung, die Legalisierung, die soziale Akzeptanz unserer Pflanze. Wir loben all die Verfechter*innen an den Frontlinien dieses jahrzehntelangen Kampfes, insbesondere Herrn George Wurth von der Hanf-Vereinigung, der auch als Referent an der ICBC Berlin beteiligt sein wird.

Die ICBC-Berlin-Veranstaltung hätte nicht besser lokalisiert noch terminiert werden können. Wir bedanken uns bei Alex Rogers und sein unglaublich professionelles Team für die Voraussicht, um dieses Event zu initiieren und wir laden alle in der Branche herzlich ein, uns vom 10. bis 12. April in Berlin zu besuchen! Mit mehr als doppelt soviel Einwohner*innen wie Kalifornien, aber in der Hälfte des Raumes, ist Deutschland der Schlüssel zur Bildung einer legalen, zuverlässigen und professionellen Cannabis-Industrie innerhalb der gesamten Europäischen Union. Das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) in Bonn ist eine Regierungsorganisation und ihr zentraler Ansprechpartner zur Thematik Cannabis. Derzeit importiert die Bundesregierung alle Medikamente für Patient*innen ausschließlich aus Kanada und den Niederlanden. Das erklärte Ziel ist eine robuste und pharmazeutische Anbau- Industrie innerhalb der eigenen Grenzen bis 2019 zu entwickeln.

Apotheken in Deutschland werden vom Staatlichen Amt für Gesundheit und Soziales betreut und sind der einzige Verteilungspunkt für vorab genehmigte medizinische Marihuana-Produkte. Die Apotheken-Situation ist wirklich ganz anders als in Amerika, mit medizinisch ausgebildeten Mitarbeiter*innen an Tausenden von Standorten. Jetzt gilt es zu lernen, wie man dieses neue Gesetz umsetzen und ihre Patient*innen effektiv bedienen soll. Es gibt zahlreiche Möglichkeiten für Unternehmen, Berater*innen und Organisationen zu helfen, die Leere, die aktuell geschätzte Notwendigkeit von über 500.000 Pfund des benötigten medizinischen Marihuanas pro Jahr zu füllen.

Die medizinische und therapeutische Verwendung von Cannabis ist äußerst wichtig, aber die Aufforderungen zur Freizeitgestaltung stehen auch für viele an der Spitze der Agenda. In den vergangenen Jahren haben ein paar deutsche Städte den Prozess der Gründung eines deutschen Marktes begonnen, und obwohl Berlin in seinen bisherigen Bemühungen gehindert wurde, können sich die bevorstehenden nationalen Wahlen positiv auf diese Bemühungen auswirken. Die Stadt Düsseldorf beispielsweise, hat ein Pilotprojekt, um Freizeit-Cannabis an Erwachsene zu verkaufen und andere deutsche Städte arbeiten an ähnlichen Maßnahmen auf Zuspruch ihrer Bürger*innen.

Deutschland ist in der Tat zentral für den Erfolg eines legalen, professionellen und praktikablen europäischen Cannabismarktes. Länder, die auch einen bedeutenden Einfluss auf die Zukunft der EU-Industrie haben, sind: Kanada, Niederlande, Schweiz, Albanien, Spanien, Großbritannien, Israel und die USA.

Wir laden Sie zur ICBC Berlin am 10.-12. April im Maritim ProArte Hotel Berlin ein. Stoppen Sie an unserem Stand und beachten Sie, dass wir für alle Teilnehmer*innen kostenlose Telefonate in die USA, kostenloses WiFi und kostenloses Plug-in, für alle, die ihre europäischen Adapter vergessen haben, zur Verfügung stellen. 🙂 Alle Kommentare oder Fragen zu diesem Beitrag werden begrüßt, indem Sie mich kontaktieren direkt unter phil@cenedella.de, +1.888.206.3264 oder über skype unter philip.j.cenedella. Danke, Dank je, Gracias und Dankeschön, – Phil


Leave a comment

What Happens When Germany Has One Million Cannabis Patients? (804,687,322 pounds?) – by Bill Griffin / Marijuanatimes.org

https://www.marijuanatimes.org/what-happens-when-germany-has-one-million-cannabis-patients/

Germany – the EU’s most populous state with 82 million people – is about to offer cannabis on medical insurance. When that happens, demand will soar.

Germany’s lower house of parliament passed a bill legalizing the production, sale and use of medical marijuana on January 19th, 2017.

The bill is restricted to the sale and use of cannabis to patients, and there is no provision for home growing. This means that all cannabis (sold legally) in Germany will come via a doctor’s prescription and from a pharmacy – just like any other prescription drug.

This ensures that the cannabis distributed is of a consistent quality and, most importantly, a consistent strength. It doesn’t ensure that it is especially interesting for cannabis connoisseurs or recreational users in terms of look, taste, smell or effects.

But thanks to the German bill, cannabis will be available through health insurance plans, which is a good thing as currently what is available in the pharmacy is a lot more expensive than what you can buy on the streets.

“Those who are severely ill need to get the best possible treatment and that includes health insurance funds paying for cannabis as a medicine for those who are chronically ill if they can’t be effectively treated any other way,” said Health Minister Hermann Groehe to Reuters.

Beginning last year, Germany has been distributing cannabis flowers through pharmacies on a case per case basis. This created a sizeable market of a few thousand patients that – due to the fact that Germany does not currently allow the cultivation of cannabis – is met through imports from (legal) cannabis producing countries, such as the Netherlands and Canada.

This is going to change. Companies are already rapidly putting together blueprints and applications to legally cultivate cannabis in Germany. Some of these companies are already importing and building up their distribution contacts and networks. As soon as they have the green light to cultivate, they will be building local facilities to meet the increasing demand.

Just how big this demand will be is currently based on estimates. Germany is a cannabis-friendly country, with 23.1% of the adult population having consumed cannabis. That’s nearly 19 million people, which given cannabis’ illegality at the time of the survey will include both medical and recreational users. To put things in perspective, Germany’s population is more than double that of California, with 82 million versus 39 million inhabitants.

Let’s say a conservative estimate of people enrolled on Germany’s medical cannabis programme will be a cool one million.

If an average patient consumes 1 gram per day – which is low or high, depending on your ailment – that would mean each patient would require 365 grams per year. Multiply that by a million and we are talking 365 metric tons – or 804,687,322 pounds. That’s a lot of pot and it’s going to take a lot of cultivation space to produce.

Who’s going to grow it?

As there is no entrance into the market for home growers or caregivers like in many U.S. states, this is going to have to be produced by companies running facilities with good agricultural practice (GAP), good distribution practice (GDP) and good manufacturing processes (GMP). You don’t get to distribute any drug in a pharmacy without such high quality control – especially in Germany.

As you can imagine, this is creating a feeding frenzy for big actors in the cannabis industry. In April, they will be convening in Berlin for the first European-based International Cannabis Business Conference. Local players with cultivation licenses will be seeking capital to meet the exacting requirements that only Germany can define. International money men will be homing in on those that can give them a great return on investment in this soon-to-be exceedingly lucrative market.

The result will be that patients in Germany will have safe access to cannabis-related medicines.

Every time a patient visits the pharmacy, they know that what they are going to get will be more or less the same as what they had the previous time. Their cannabis will be grown without human intervention in automated cultivation rooms. Biological engineers will be monitoring the grow installation and laboratories will test the end product to ensure that the cannabinoid profiles will remain consistent from batch to batch.

Once complete, the buds will be irradiated of soil microorganisms and they will be packaged and stored in perfect conditions until it is handed to the patient in a white paper bag and a smile from their local pharmacist.

All cannabis culture has been methodically stripped out of the cannabis that will be distributed.

As a hobby home grower and recreational user – self-medicating in the absence of legislation that will allow me to get a prescription – I find this a rather sad ending to the calls for legalisation from millions of Europeans over the last 50 years. I have to admit, for many patients getting true medicinal grade cannabis free from pests, diseases or any adulterants is a good thing; growing cannabis to this level of consistency at home is virtually impossible. I’m not discounting it for recreational use, but in the way we class “medicine” in modern society it is not something that we produce in our homes – that’s called a “remedy”. Collectively and with empirical data to back it up we have agreed that medicine should be sterile. Cannabis from your greenhouse is far from sterile.

This arrangement will line the pockets of big investors and local entrepreneurs, but will also provide safe medicine to those who need it most. People who would never dream of growing their own or sourcing through a network of growers will be able to benefit from a medicine that has no adverse side effects.

The genie will be well and truly out of the bottle. More people in society will come to accept cannabis and see that the negative propaganda of the past was based on lies.

Increased cultivation, distribution and monitoring of patients will provide data that will have positive results. Science will finally be able to study cannabis, cannabinoids, terpenes and all the other components that make up the cannabis plant. This will lead to more breakthroughs and medical applications.

Germany is the largest population in Europe, and once they show that this can work, other countries will inevitably follow their lead.

However, for many activists this is not the end game; cannabis through pharmacies is just phase one. Ultimately, Germany will legalize cannabis for recreational use. That’s how it works, just look at the pattern in the U.S. and Canada. First, you legalize for medical use, then you decriminalize for recreational use, then you get full on legal cannabis to anyone who is old enough to buy it.

When that day comes there won’t just be one million medical patients; the full 23.1% of the German population that tried it will be able to consume without the guilt or anxiety that prohibition creates. This demand could only be met from decentralised local producers. This is where the connoisseurs will benefit. I dream of the day when, instead of dropping in my local wine shop, I stop by my local cannabis dispensary to see what delights they have on offer. It’s some way off at the moment, but my money’s on this becoming a reality in the not-too-distant future.


Leave a comment

Foreign Corrupts Practices Act (FCPA) – by Simone Cimiluca Radzins

https://www.cannabisbusinessexecutive.com/2017/03/building-global-cannabis-brand-heres-one-law-need-know/

Many US brands are already working in the international cannabis market, through licensing out their product/service to other countries. But beyond the glory of carrying an international brand, there are certain risks of taking your cannabis brand global.Barriers to entry are tough in a foreign market, and making personal connections with foreign officials is key to integrating a brand into a new market. However, what did it take to get the brand into that country? Did it take a few meals or gifts to someone from the government? If so, there could be a violation of the Foreign Corrupts Practices Act.

What is the Foreign Corrupts Practices Act (FCPA)?

Congress enacted the FCPA in 1977 after revelations of widespread global corruption and discovering that more than 400 U.S. companies had paid hundreds of millions of dollars in bribes to foreign government officials to secure business overseas. The Department of Justice (DOJ) and SEC started heavily pursuing companies (Walmart, Seimans, etc) in 2012.

The FCPA is known primarily for two of its main provisions, one that concerns bribery of foreign officials and the other that addresses accounting transparency requirements under the Securities Exchange Act of 1934.

As mentioned above, there are two main provisions in the FCPA, which include:

  • Bribery of Foreign Officials: It is illegal for companies and individuals to influence a foreign official (or third parties/intermediaries to foreign officials) with any personal payments or rewards. This includes not only cash payments; it also may include travel and entertainment expenses or expensive gifts.
  • Accounting Transparency: The FCPA requires companies whose securities are listed in the United States to meet its accounting provisions.The accounting provisions also prohibit individuals and businesses from knowingly falsifying books and records or knowingly failing to implement internal controls.

How do you define what type of payments would be in violation of the FCPA? According to the FCPA, “payments intended to induce or influence a foreign official to use his or her position in order to assist … in obtaining or retaining business for or with, or directing business to, any person.”  Obtaining or retaining business can be defined as winning a contract, influencing the procurement process, avoiding contract termination, and more.

What you can do to ensure compliance with the FCPA

Companies engaging in business in emerging markets face a uniquely increased level of corruption and regulatory risk, but like everything – there are solutions. Here are three things that your company can do to mitigate FCPA risk.

1. Training: Implement a basic training program at your company. This training program should include all forms of compliance (code of conduct, sexual harassment, etc) and a separate FCPA training program.  Ensure that the accounting department, sales team, executive management, and the board of directors are trained.

2. Contracts: Include a FCPA clause in all contracts for customers and vendors.

3.  Monitoring: Continually monitor all controls that are in place to mitigate FCPA. This includes review of contracts and training requirements. An internal audit of transactions is also recommended depending on the size of operations.

FCPA does not mean zero contact with foreign officials. Under the FCPA, individuals still are able to engage and have an open dialogue with government officials. Gifts of “reasonable” value are allowed, if allowed by local law. However, there needs to be a clear internal structure to ensure full compliance with the law.

If you’re in cannabis, you’re in compliance. Global compliance is another game, make sure you’re prepared!